Zack Williams is an M.D./Ph.D. student at Vanderbilt University, in Nashville, Tennessee, currently pursuing a joint Ph.D. in neuroscience and hearing and speech sciences. His research focuses on the development and evaluation of psychological measures for use in adults on the autism spectrum. He is particularly interested in the assessment of co-occurring psychiatric and psychosomatic disorders in autistic adults and the development of evidence-based treatments for these conditions.
Zachary Williams
M.D./Ph.D. student
Vanderbilt University
From this contributor
Common sensory response scores may miss important variations
A person’s “overall” score on sensory-seeking, hyperreactive or hyporeactive tendencies may obscure nuances in their individual sensory experience.
Common sensory response scores may miss important variations
By
Zachary Williams, Tiffany Woynaroski
22 February 2024 | 5 min read
Explore more from The Transmitter
Neurons fuel lung tumors that have spread to brain
Functional synapses between brain cells and cancer cells are key to the metastatic growth, according to new findings from two independent teams.
Neurons fuel lung tumors that have spread to brain
Functional synapses between brain cells and cancer cells are key to the metastatic growth, according to new findings from two independent teams.
By
Sarah DeWeerdt
6 October 2025 | 7 min listen
Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.
Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.
By
Calli McMurray
3 October 2025 | 2 min read
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
By
Claudia López Lloreda
2 October 2025 | 6 min read